Welltower Inc (NYSE:WELL) has earned a consensus rating of “Buy” from the eighteen ratings firms that are covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $74.79.
WELL has been the topic of several recent analyst reports. BMO Capital Markets cut their price target on shares of AKITA Drilling from C$5.00 to C$3.50 in a report on Tuesday, May 7th. Morgan Stanley set a $111.00 price target on shares of Procter & Gamble and gave the company a “buy” rating in a report on Thursday, March 28th. Deutsche Bank boosted their target price on shares of Welltower from $61.00 to $71.00 and gave the company a “hold” rating in a report on Friday, March 29th. Scotiabank set a $80.00 target price on shares of Welltower and gave the company a “hold” rating in a report on Friday, June 14th. Finally, Raymond James initiated coverage on shares of Adverum Biotechnologies in a report on Thursday, June 13th. They set a “market perform” rating on the stock.
In other news, CEO Thomas J. Derosa sold 19,307 shares of Welltower stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $77.90, for a total value of $1,504,015.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.15% of the company’s stock.
Shares of Welltower stock traded down $0.36 on Friday, hitting $84.29. The stock had a trading volume of 34,558 shares, compared to its average volume of 2,509,898. The firm has a market cap of $34.18 billion, a PE ratio of 20.92, a price-to-earnings-growth ratio of 4.15 and a beta of 0.29. The firm has a 50-day moving average of $83.05. Welltower has a one year low of $60.74 and a one year high of $86.91. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.84 and a current ratio of 1.84.
Welltower (NYSE:WELL) last released its quarterly earnings results on Tuesday, April 30th. The real estate investment trust reported $1.02 earnings per share for the quarter, meeting the consensus estimate of $1.02. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Welltower had a net margin of 13.06% and a return on equity of 4.97%. The firm’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.99 earnings per share. On average, equities analysts anticipate that Welltower will post 4.19 EPS for the current fiscal year.
Welltower Inc (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Recommended Story: Street Name
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.